The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding

European Journal of Immunology

Volumn 30, Issue 1, 2000, Pages 245-253

  Lesley, Jayne ^a   English, Nicole ^a   Charles, Catherine ^a   Hyman, Robert ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

CD44; Cytoplasmic domain; Dimerization; Hyaluronan binding; Transmembrane domain

Indexed keywords

CHIMERIC PROTEIN; HERMES ANTIGEN; HYALURONIC ACID; INTEGRIN; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DIMERIZATION; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD44; CELL LINE; CELL MEMBRANE; CYTOPLASM; DIMERIZATION; HYALURONIC ACID; MICE; MICE, INBRED AKR; MOLECULAR SEQUENCE DATA; TRANSFECTION;

EID: 0033987011     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/1521-4141(200001)30:1<245::AID-IMMU245>3.0.CO;2-X     Document Type: Article

References (52)

1. Lesley, J., Howes, N., Perschl, A. and Hyman, R., Hyaluronan binding function of CD44 is transiently activated on T cells during an in vivo immune response. J. Exp. Med. 1994. 180: 383-387.
2. Murakami, S., Miyake, K., June, C. H., Kincade, P. W. and Hodes, R. J., IL-5 induces a Pgp-1 (CD44) bright B cell subpopulation that is highly enriched in proliferative and Ig secretory activity and binds to hyaluronate. J. Immunol. 1990. 145: 3618-3627.
3. hi population that binds specifically to hyaluronate. J. Immunol. 1991. 146: 1422-1427.
4. Liao, H.-X., Levesque, M. C., Patton, K., Bergamo, B., Jones, D., Moody, M. A., Telen, M. J. and Haynes, B. F., Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies. J. Immunol. 1993. 151: 6490-6499.
5. DeGrendele, H. C., Estess, P., Picker, L. J. and Siegelman, M. H., CD44 and its ligand hyaluronate mediate rolling under physiologic flow: a novel lymphocyte-endothelial cell primary adhesion pathway. J. Exp. Med. 1996. 183: 1119-1130.
6. DeGrendele, H. C., Estess, P. and Siegelman, M. H., Requirement for CD44 in activated T cell extravasation into an inflammatory site. Science 1997. 278: 672-675.
7. Liu, D., Zhang, D., Mori, H. and Sy, M.-S., Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain. Cell Immunol. 1996. 174: 73-83.
8. Maiti, A., Maki, G. and Johnson, P., TNF-α induction of CD44-mediated leukocyte adhesion by sulfation. Science 1998. 282: 941-943.
9. Lesley, J., He, Q., Miyake, K., Hamann, A., Hyman, R. and Kincade, P., Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. J. Exp. Med. 1992. 175: 257-266.
10. Lesley, J. and Hyman, R., CD44 can be activated to function as an hyaluronic acid receptor in normal murine T-cells. Eur J. Immunol. 1992. 22: 2719-2723.
11. Aruffo, A., Stamenkovic, I., Melnick, M., Underbill, C. B. and Seed, B., CD44 is the principal cell surface receptor for hyaluronate. Cell 1990. 61: 1303-1313.
12. English, N., Lesley, J. and Hyman, R., Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Res. 1998. 58: 3736-3742.
13. Lesley, J., Hyman, R., English, N., Catteral, J. and Turner, G., CD44 in inflammation and metastasis. Glyconjugate J. 1997. 14: 611-622.
14. Pure, E., Camp, R., Peritt, D., Panettieri, R., Lazaar, A. and Nayak, S., Defective phosphorylation and hyaluronate binding of CD44 with point mutations in the cytoplasmic domain. J. Exp. Med. 1995. 181: 55-62.
15. Neame, S. and Isacke, C., Phosphorylation of CD44 in vivo requires both Ser 323 and Ser 325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells. EMBO J. 1992. 11: 4733-4738.
16. Liu, D., Liu, T. and Sy, M. S., Identification of two regions in the cytoplasmic domain of CD44 through which PMA, calcium, and forskolin differentially regulate the binding of CD44 to hyaluronic acid. Cell. Immunol. 1998. 190: 132-140.
17. Lokeshwar, V., Fregien, N. and Bourguignon, L., Ankyrin-binding domain of CD44 (GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J. Cell Biol. 1994. 126: 1099-1109.
18. Uff, C., Neame, S. and Isacke, C., Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism. Eur. J. Immunol. 1995. 25: 1883-1887.
19. Legg, J. W. and Isacke, C. M., Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr. Biol. 1998. 8: 705-708.
20. Perschl, A., Lesley, J., English, N., Trowbridge, I. and Hyman, R., Role of CD44 cytoplasmic domain in hyaluronan binding. Eur. J. Immunol. 1995. 25: 495-501.
21. Liu, D. and Sy, M.-S., A cysteine residue located in the transmembrane domain of CD44 is important in binding of CD44 to hyaluronic acid. J. Exp. Med. 1996. 183: 1987-1994.
22. Liu, D. and Sy, M.-S., Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. J. Immunol. 1997. 159: 2702-2711.
23. Amara, J., Clackson, T., Rivera, V., Guo, T., Keenan, T., Natesan, S., Pollock, R., Yang, W., Courage, N., Holt, D. and Gilman, M., A versatile synthetic dimerizer for the regulation of protein-protein interactions. Proc. Natl. Acad. Sci. USA 1997. 94: 10618-10623.
24. 3. J. Cell Biol. 1998. 141: 1685-1695.
25. Lesley, J., Hyman, R. and Kincade, P., CD44 and its interaction with extracellular matrix. Adv. Immunol. 1993. 54: 271-335.
26. Lesley, J., Schulte, R. and Hyman, R., Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1. Exp. Cell Res. 1990. 187: 224-233.
27. Stewart, M. and Hogg, N., Regulation of leukocyte integrin function: Affinity vs. avidity. J. Cell. Biochem. 1996. 61: 554-561.
28. Dustin, M. L. and Springer, T. A., Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu. Rev. Immunol. 1991. 9: 27-66.
29. Shattil, S., Kashiwagi, H. and Pampori, N., Integrin signaling: The platelet paradigm. Blood 1998. 91: 2645-2657.
30. Bazzoni, G. and Hemler, M., Are changes in integrin affinity and conformation overemphasized? Trends Biochem. Sci. 1998. 23: 30-34.
31. Lesley, J. and Hyman, R., CD44 Structure and Function. Front. Biosci. 1998. 3: 616-630.
32. Perschl, A., Lesley, J., English, N., Hyman, R. and Trowbridge, I., Transmembrane domain of CD44 is required for its detergent insolubility in fibroblasts. J. Cell Sci. 1995. 108: 1033-1041.
33. Ozawa, M. and Kemler, R., The membrane-proximal region of the E-cadherin cytoplasmic domain prevents dimerization and negatively regulates adhesion activity. J. Cell Biol. 1998. 142: 1605-1613.
34. Kucik, D., Dustin, M., Miller, J. and Brown, E., Adhesion-activating phorbol ester increases the mobility of leukocyte intgrin LFA-1 in cultured lymphocytes. J. Clin. Invest. 1996. 97: 2139-2144.
35. Lesley, J., Kincade, P. and Hyman, R., Antibody-induced activation of the hyaluronan receptor function of CD44 requires multivalent binding by antibody. Eur. J. Immunol. 1993. 23: 1902-1909.
36. Katoh, S., Zheng, Z., Oritani, K., Shimozato, T. and Kincade, P., Glycosylation of CD44 negatively regulates its recognition of hyaluronan. J. Exp. Med. 1995. 182: 419-429.
37. Hathcock, K. S., Hirano, H., Murakami, S. and Hodes, R. J., CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid. J. Immunol. 1993. 151: 6712-6722.
38. Bennett, K. L., Modrell, B., Greenfield, B., Bartolazzi, A., Stamenkovic, I., Peach, R., Jackson, D., Spring, F. and Aruffo, A., Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons. J. Cell Biol. 1995. 131: 1623-1633.
39. Lesley, J., English, N., Perschl, A., Gregoroff, J. and Hyman, R., Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J. Exp. Med. 1995. 182: 431-437.
40. Dasgupta, A., Takahashi, K., Cutler, M. and Tanabe, K. K., O-linked glycosylation modifies CD44 adhesion to hyaluronate in colon carcinoma cells. Biochem. Biophys. Res. Commun. 1996. 227: 110-117.
41. Bartolazzi, A., Nocks, A., Aruffo, A., Spring, F. and Stamenkovic, I., Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 1996. 132: 1199-1208.
42. Takahashi, K., Stamenkovic, I., Cutler, M., Dasgupta, A. and Tanabe, K. K., Keratan sulfate modification of CD44 modulates adhesion to hyaluronate. J. Biol. Chem. 1996. 271: 9490-9496.
43. Zheng, Z., Cummings, R., Pummill, P. and Kincade, P., Growth as a solid tumor or reduced glucose concentrations in culture reversibly induce CD44-mediated hyaluronan recognition by Chinese hamster ovary cells. J. Clin. Invest. 1997. 100: 1217-1229.
44. Esford, L. E., Maiti, A., Bader, S. A., Tufaro, F. and Johnson, P., Analysis of CD44 interactions with hyaluronan in murine L cell fibroblasts deficient in glycosaminoglycan synthesis: a role for chondroitin sulfate. J. Cell Sci. 1998. 111: 1021-1029.
45. Skelton, T. P., Zeng, C., Nocks, A. and Stamenkovic, I., Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J. Cell Biol. 1998. 140: 431-446.
46. Isacke, C., The role of the cytoplasmic domain in regulating CD44 function. J. Cell Sci. 1994. 107: 2353-2359.
47. - defect, Immunogenetics 1980. 10: 261-271.
48. Trowbridge, I. S., Lesley, J., Schulte, R., Hyman, R. and Trotter, J., Biochemical characterization and cellular distribution of a polymorphic, murine cell-surface glycoprotein expressed on lymphoid tissues. Immunogenetics 1982. 15: 299-312.
49. Qin, H. and Gunning, P., The 3'-end of the human β-actin gene enhances activity of the β-actin expression vector system: construction of improved vectors. J. Biochem. Biophys. Methods 1997. 36: 63-72.
50. He, Q., Lesley, J., Hyman, R., Ishihara, K. and Kincade, P., Molecular isoforms of murine CD44 and evidence that the membrane proximal domain is not critical for hyaluronate recognition. J. Cell. Biol. 1992. 119: 1711-1719.
51. Southern, P. J. and Berg, P., Transformation of mammalian cells to antibiotic resistence with a bacterial gene under control of the SV40 early region promoter. J. Appl. Mol. Genet. 1982. 1: 327-341.
52. Stamenkovic, I., Amiot, M., Pesando, J. M. and Seed, B., A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family. Cell 1989. 56: 1057-1062.